| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.5M | — | -59.7% |
| Cost of Revenue | $3.1M | — | -24.3% |
| R&D Expense | $49.9M | — | -29.6% |
| SG&A Expense | $37.8M | — | -22.9% |
| Operating Income | -$71.4M | — | +19.8% |
| Pre-tax Income | -$76.1M | — | +16.2% |
| Income Tax | -$80K | — | -190.9% |
| Net Income | -$82.6M | — | +9.2% |
| EPS (Basic) | -$1.39 | — | +17.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $143.9M | -14.0% | -54.0% |
| Accounts Receivable | $19.8M | -17.5% | -24.6% |
| Current Assets | $410.0M | -13.1% | -27.4% |
| Total Assets | $1.03B | -7.7% | -20.1% |
| Current Liabilities | $79.6M | -17.1% | -31.2% |
| Total Liabilities | $589.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$46.7M | — | +9.4% |
| Capital Expenditures | $1.9M | — | -74.6% |
| Investing Cash Flow | $23.1M | — | +111.6% |
| Financing Cash Flow | -$19K | — | +90.8% |
| Free Cash Flow | -$48.6M | — | +17.8% |
| -8.7% |
| Stockholders' Equity | $443.2M | -12.9% | -31.6% |